- 2015
-
Neopenda founded at Columbia University.
First needs assessment in Uganda.
Participated in Relevant Health Accelerator program.
- 2016
-
Initial non-dilutive fundraising.
Neopenda HQ moved to Chicago, IL.
User and market research in Uganda.
- 2017
-
Complete prototype system build.
Feedback from over 100 users in Uganda.
PCT patent filed.
- 2018
-
Opened office in Kampala, Uganda.
Participated in Techstars Chicago.
Named to MIT Solve Frontlines of Health class.
Clinical pilot study at Tufts Medical Center in Boston, MA.
- 2019
-
Raised seed funding round.
Clinical pilot study at Tufts Medical Center in Boston, MA.
Clinical pilot study at Jinja Regional Referral Hospital in Jinja, Uganda.
Design for Manufacturing of neoGuard™.
- 2020
-
Received regulatory approval in Kenya.
- 2021
-
Received CE Mark approval.
Entered the market in Kenya.
